Publication:
The influence of the carrier molecule on amoxicillin recognition by specific IgE in patients with immediate hypersensitivity reactions to betalactams.

dc.contributor.authorAriza, Adriana
dc.contributor.authorMayorga, Cristobalina
dc.contributor.authorSalas, María
dc.contributor.authorDoña, Inmaculada
dc.contributor.authorMartín-Serrano, Ángela
dc.contributor.authorPérez-Inestrosa, Ezequiel
dc.contributor.authorPérez-Sala, Dolores
dc.contributor.authorGuzmán, Antonio E
dc.contributor.authorMontañez, María I
dc.contributor.authorTorres, María J
dc.date.accessioned2024-01-16T12:16:37Z
dc.date.available2024-01-16T12:16:37Z
dc.date.issued2016-10-12
dc.description.abstractThe optimal recognition of penicillin determinants, including amoxicillin (AX), by specific IgE antibodies is widely believed to require covalent binding to a carrier molecule. The nature of the carrier and its contribution to the antigenic determinant is not well known. Here we aimed to evaluate the specific-IgE recognition of different AX-derived structures. We studied patients with immediate hypersensitivity reactions to AX, classified as selective or cross-reactors to penicillins. Competitive immunoassays were performed using AX itself, amoxicilloic acid, AX bound to butylamine (AXO-BA) or to human serum albumin (AXO-HSA) in the fluid phase, as inhibitors, and amoxicilloyl-poli-L-lysine (AXO-PLL) in the solid-phase. Two distinct patterns of AX recognition by IgE were found: Group A showed a higher recognition of AX itself and AX-modified components of low molecular weights, whilst Group B showed similar recognition of both unconjugated and conjugated AX. Amoxicilloic acid was poorly recognized in both groups, which reinforces the need for AX conjugation to a carrier for optimal recognition. Remarkably, IgE recognition in Group A (selective responders to AX) is influenced by the mode of binding and/or the nature of the carrier; whereas IgE in Group B (cross-responders to penicillins) recognizes AX independently of the nature of the carrier.
dc.format.page35113es_ES
dc.format.volume6es_ES
dc.identifier.doi10.1038/srep35113
dc.identifier.e-issn2045-2322es_ES
dc.identifier.journalScientific reportses_ES
dc.identifier.otherhttp://hdl.handle.net/10668/10528
dc.identifier.pubmedID27731424es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17163
dc.language.isoeng
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAmoxicillin
dc.subject.meshAnaphylaxis
dc.subject.meshAntibody Specificity
dc.subject.meshButylamines
dc.subject.meshCarrier Proteins
dc.subject.meshCross Reactions
dc.subject.meshDrug Hypersensitivity
dc.subject.meshFemale
dc.subject.meshHaptens
dc.subject.meshHumans
dc.subject.meshHypersensitivity, Immediate
dc.subject.meshImmunoglobulin E
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPenicillins
dc.subject.meshPolylysine
dc.subject.meshSerum Albumin, Human
dc.subject.meshUrticaria
dc.subject.meshYoung Adult
dc.subject.meshbeta-Lactams
dc.titleThe influence of the carrier molecule on amoxicillin recognition by specific IgE in patients with immediate hypersensitivity reactions to betalactams.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files